Related Experiment Video

Updated: Aug 17, 2026

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

Cefoperazone therapy of serious infections

J Temple, W J Mogabgab

    Clinical Therapeutics
    |January 1, 1982
    PubMed

    Insights

    Cefoperazone effectively treated serious adult infections, including pneumonia and septicemia, even against resistant bacteria. The antibiotic showed excellent clinical results with no observed adverse effects on renal function.

    Area of Science:

    • Infectious Diseases
    • Pharmacology
    • Clinical Microbiology

    Background:

    • Serious bacterial infections pose significant therapeutic challenges.
    • The emergence of multi-antibiotic resistant strains necessitates novel treatment options.
    • Cefoperazone is a third-generation cephalosporin antibiotic.

    Purpose of the Study:

    • To evaluate the efficacy and safety of cefoperazone in treating serious infections in adults.
    • To assess the clinical and bacteriological response to cefoperazone therapy.
    • To determine the impact of cefoperazone on renal function.

    Main Methods:

    • A clinical trial involving 64 adult patients with serious infections.
    • Infections included pneumonias, urinary tract infections, septicemia, osteomyelitis, and joint infections.
    • Etiological agents, including multi-antibiotic resistant strains, were identified and tested for sensitivity.

    Main Results:

    • Cefoperazone demonstrated excellent clinical response in the majority of patients.
    • Bacteriological responses were consistent with patient outcomes, not indicating cefoperazone inadequacy.
    • No adverse effects on renal function were observed, even in patients with pre-existing renal impairment.

    Conclusions:

    • Cefoperazone is a suitable and effective therapeutic agent for serious adult infections.
    • The antibiotic is well-tolerated, with a favorable safety profile regarding renal function.
    • Cefoperazone provides a valuable treatment option, particularly against multi-antibiotic resistant organisms.

    More Related Videos

    Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses11:17

    Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

    Published on: August 30, 2018

    Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos11:20

    Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos

    Published on: May 12, 2020

    Related Concept Videos

    Drugs for Treatment of Diarrhea-Predominant IBS01:17

    Drugs for Treatment of Diarrhea-Predominant IBS

    Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
    Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
    Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

    Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

    Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
    Pneumonia IV: Management01:28

    Pneumonia IV: Management

    The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
    Bacterial Pneumonia Treatment
    For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
    Urinary Tract Infection IV: Nursing Management01:17

    Urinary Tract Infection IV: Nursing Management

    In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs like...
    Acute Pyelonephritis II: Diagnostic Studies and Management01:28

    Acute Pyelonephritis II: Diagnostic Studies and Management

    Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
    Inhibitors of Bacterial DNA Synthesis01:28

    Inhibitors of Bacterial DNA Synthesis

    Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...